Literature DB >> 6365784

Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.

F A Klipstein, R F Engert, J D Clements, R A Houghten.   

Abstract

Although cholera toxin (CT), Escherichia coli heat-labile toxin (LT), and their B subunits are known to be immunologically related, the ability of each to raise an antitoxin response that provides equally strong cross-protection against active challenge with pure heterologous toxin has not been examined previously. We immunized rats with pure preparations of the B subunits of human LT, porcine LT, and CT. Immunization with either of the LT B subunits raised greater than or equal to fourfold increases in specific mucosal immunoglobulin A antitoxin titers to homologous and heterologous LT and CT B subunits, thereby providing strong protection against active challenge in ligated ileal loops with all three respective holotoxins and with a viable LT-producing E. coli strain. In contrast, immunization with the CT B subunit raised a greater than or equal to fourfold increase in antitoxin titers only to itself and provided strong protection only against challenge with the CT holotoxin. Conjugation of the CT B subunit with the E. coli heat-stable toxin by the carbodiimide reaction yielded a cross-linked immunogen with equal antigenicity for both components; immunization with this conjugate raised greater than or equal to fourfold increases in antitoxin titers to both components, but it provided significant protection only against challenge with a viable heat-stable toxin-producing E. coli strain and not to an LT-producing E. coli strain. These observations indicate that immunization with the LT B subunits raises a heterologous antitoxin response that extends to the CT B subunit, thereby providing equally strong protection against LT and CT; however, immunization with the CT B subunit raises principally a homologous antitoxin response, so that this immunogen provides strong protection only against CT.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365784      PMCID: PMC264253          DOI: 10.1128/iai.43.3.811-816.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Subunit structure and N-terminal amino acid sequence of the three chains of cholera enterotoxin.

Authors:  D G Klapper; R A Finkelstein; J D Capra
Journal:  Immunochemistry       Date:  1976-07

3.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Properties of homogeneous heat-labile enterotoxin from Escherichia coli.

Authors:  J D Clements; R J Yancey; R A Finkelstein
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

5.  Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants.

Authors:  J J Mekalanos; R J Collier; W R Romig
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

6.  Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Purification and characterization of heat-stable enterotoxin produced by a strain of E. coli pathogenic for man.

Authors:  S J Staples; S E Asher; R A Giannella
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

8.  Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

10.  Modes of action of enterotoxins from Vibrio cholerae and EScherichia coli.

Authors:  M Field
Journal:  Rev Infect Dis       Date:  1979 Nov-Dec
View more
  4 in total

1.  Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge.

Authors:  Sergio Rosales-Mendoza; Ruth Elena Soria-Guerra; Rubén López-Revilla; Leticia Moreno-Fierros; Angel Gabriel Alpuche-Solís
Journal:  Plant Cell Rep       Date:  2007-09-15       Impact factor: 4.570

2.  A completely synthetic toxoid vaccine containing Escherichia coli heat-stable toxin and antigenic determinants of the heat-labile toxin B subunit.

Authors:  R A Houghten; R F Engert; J M Ostresh; S R Hoffman; F A Klipstein
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

3.  Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.

Authors:  J D Clements; S El-Morshidy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

4.  Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.